A survey of algorithms for transforming molecular dynamics data into metadata for in situ analytics based on machine learning methods

Machine learning, artificial intelligence, and chemistry: how smart algorithms are reshaping simulation and the laboratory

Machine learning and artificial intelligence are increasingly gaining in prominence through image analysis, language processing, and automation, to name a few applications. Machine learning is also making profound changes in chemistry. From revisiting decades-old analytical techniques for the purpose of creating better calibration curves, to assisting and accelerating traditional in silico simulations, to automating entire scientific workflows, to being used as an approach to deduce underlying physics of unexplained chemical phenomena, machine learning and artificial intelligence are reshaping chemistry, accelerating scientific discovery, and yielding new insights. This review provides an overview of machine learning and artificial intelligence from a chemist’s perspective and focuses on a number of examples of the use of these approaches in computational chemistry and in the laboratory.

High frequency accuracy and loss data of random neural networks trained on image datasets

Neural Networks (NNs) are increasingly used across scientific domains to extract knowledge from experimental or computational data. An NN is composed of natural or artificial neurons that serve as simple processing units and are interconnected into a model architecture; it acquires knowledge from the environment through a learning process and stores this knowledge in its connections. The learning process is conducted by training. During NN training, the learning process can be tracked by periodically validating the NN and calculating its fitness. The resulting sequence of fitness values (i.e., validation accuracy or validation loss) is called the NN learning curve. The development of tools for NN design requires knowledge of diverse NNs and their complete learning curves. Generally, only final fully-trained fitness values for highly accurate NNs are made available to the community, hampering efforts to develop tools for NN design and leaving unaddressed aspects such as explaining the generation of an NN and reproducing its learning process. Our dataset fills this gap by fully recording the structure, metadata, and complete learning curves for a wide variety of random NNs throughout their training. Our dataset captures the lifespan of 6000 NNs throughout generation, training, and validation stages. It consists of a suite of 6000 tables, each table representing the lifespan of one NN. We generate each NN with randomized parameter values and train it for 40 epochs on one of three diverse image datasets (i.e., CIFAR-100, FashionMNIST, SVHN). We calculate and record each NN's fitness with high frequency-every half epoch-to capture the evolution of the training and validation process. As a result, for each NN, we record the generated parameter values describing the structure of that NN, the image dataset on which the NN trained, and all loss and accuracy values for the NN every half epoch. We put our dataset to the service of researchers studying NN performance and its evolution throughout training and validation. Statistical methods can be applied to our dataset to analyze the shape of learning curves in diverse NNs, and the relationship between an NN's structure and its fitness. Additionally, the structural data and metadata that we record enable the reconstruction and reproducibility of the associated NN.

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis

Mycobacterium tuberculosis is the causative agent of TB and was estimated to cause 1.4 million death in 2019, alongside 10 million new infections. Drug resistance is a growing issue, with multi-drug resistant infections representing 3.3% of all new infections, hence novel antimycobacterial drugs are urgently required to combat this growing health emergency. Alongside this, increased knowledge of gene essentiality in the pathogenic organism and larger compound databases can aid in the discovery of new drug compounds. The number of protein structures, X-ray based and modelled, is increasing and now accounts for greater than > 80% of all predicted M. tuberculosis proteins; allowing novel targets to be investigated. This review will focus on structure-based in silico approaches for drug discovery, covering a range of complexities and computational demands, with associated antimycobacterial examples. This includes molecular docking, molecular dynamic simulations, ensemble docking and free energy calculations. Applications of machine learning onto each of these approaches will be discussed. The need for experimental validation of computational hits is an essential component, which is unfortunately missing from many current studies. The future outlooks of these approaches will also be discussed.